Early glibenclamide treatment in a clinical newborn with KCNJ11 gene mutation

Diabetes Care. 2007 Oct;30(10):e104. doi: 10.2337/dc07-1318.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Amino Acid Substitution
  • Genetic Carrier Screening
  • Glyburide / therapeutic use*
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Infant
  • Male
  • Mutation*
  • Potassium Channels, Inwardly Rectifying / genetics*
  • Treatment Outcome

Substances

  • Hypoglycemic Agents
  • Kir6.2 channel
  • Potassium Channels, Inwardly Rectifying
  • Glyburide